Nabi Biopharmaceuticals Announces Withdrawal of Biotest's Indemnification Claim
01. Juni 2009 09:15 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., June 1, 2009 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that Biotest Pharmaceuticals Corporation has withdrawn and released a claim representing $50.4...
Nabi Biopharmaceuticals Announces First Quarter 2009 Financial Results
06. Mai 2009 16:05 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., May 6, 2009 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced its first quarter financial results for the three month period ended March 28, 2009. The Company...
Nabi Biopharmaceuticals to Announce 2009 First Quarter Financial Results On May 6, 2009
28. April 2009 10:30 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., April 28, 2009 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that it will report its 2009 first quarter financial results on Wednesday, May 6, 2009, after...
Nabi Biopharmaceuticals Announces Date for 2009 Annual Meeting of Shareholders
01. April 2009 13:00 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., April 1, 2009 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today that its 2009 Annual Meeting of Shareholders will be held on Friday, May 22, 2009 at 10:00 a.m....
Nabi Biopharmaceuticals Announces Fourth Quarter and Full-Year 2008 Financial Results
11. März 2009 16:05 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., March 11, 2009 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced fourth quarter and year-end financial results for the three and twelve month periods ended...
Nabi Biopharmaceuticals to Present At the Noble Financial Capital Markets Boston Uncommon Conference
06. März 2009 10:00 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., March 6, 2009 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that Dr. Raafat Fahim, President and Chief Executive Officer, will participate in the Noble...
Nabi Biopharmaceuticals to Announce 2008 Fourth Quarter and Year-End Financial Results On March 11, 2009
05. März 2009 09:30 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., March 5, 2009 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that it will report its 2008 fourth quarter and full-year financial results on Wednesday, March...
Nabi Biopharmaceuticals Reaches Special Protocol Agreement With FDA for NicVAX(r) Phase 3 Trial Protocol
23. Dezember 2008 09:25 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Dec. 23, 2008 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced it has reached agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol...
Nabi Biopharmaceuticals Enters Clinical Initiative With US Military to Advance PentaStaph(tm)
17. Dezember 2008 09:00 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Dec. 17, 2008 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) has entered into a Cooperative Research and Development Agreement (CRADA) with the Uniformed Services University...
Nabi Biopharmaceuticals Significantly Enhances Gram-Positive Patent Portfolio
02. Dezember 2008 09:15 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Dec. 2, 2008 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced the receipt of two patents for key components of PentaStaph(tm), the Company's next-generations S....